These changes included the increased liver indices, mild increases in serum AST and ALT activities, and elevated serum and liver TG levels, in agreement of the literature (Li YJ et al., 2023; Nie et al., 2023; Wang et al., 2020), which demonstrates the effective modeling of NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.